Long noncoding RNAs in patients with acute myocardial infarction

Area of Science:

• Molecular Biology
• Cardiovascular Research
• Genomics

Background:

• Long noncoding RNAs (lncRNAs) are emerging regulators of gene expression.
• Their role in myocardial ischemia, particularly myocardial infarction (MI), remains largely unexplored.

Purpose of the Study:

• To quantify the expression of specific long noncoding RNAs (lncRNAs) in patients diagnosed with acute myocardial infarction (MI).
• To investigate the potential of these lncRNAs as predictive biomarkers for adverse cardiac outcomes.

Main Methods:

• Quantitative polymerase chain reaction (qPCR) was used to measure the expression of five lncRNAs in peripheral blood cells from 414 acute MI patients.
• Expression levels were compared between MI patients and healthy volunteers, and stratified by MI type (STEMI vs. NSTEMI).
• Statistical analyses assessed associations with clinical factors and prediction of left ventricular dysfunction.

Main Results:

• Expression levels of hypoxia inducible factor 1A antisense RNA 2, KCNQ1OT1, and metastasis-associated lung adenocarcinoma transcript 1 were elevated in MI patients compared to controls.
• ANRIL expression was lower in MI patients and associated with clinical factors like age and hypertension.
• ANRIL and KCNQ1OT1 improved the prediction of left ventricular dysfunction when added to existing clinical models.

Conclusions:

• Blood cell long noncoding RNA (lncRNA) levels are significantly altered following myocardial infarction (MI).
• Specific lncRNAs, notably ANRIL and KCNQ1OT1, demonstrate potential as predictive biomarkers for left ventricular dysfunction post-MI.
• Further research into the functional roles of lncRNAs in cardiac disease is warranted.